ANL 11.28 Increased By ▲ 1.00 (9.73%)
ASC 9.50 Increased By ▲ 0.41 (4.51%)
ASL 11.24 Increased By ▲ 0.25 (2.27%)
AVN 78.01 Increased By ▲ 0.41 (0.53%)
BOP 5.51 Increased By ▲ 0.11 (2.04%)
CNERGY 5.41 Increased By ▲ 0.08 (1.5%)
FFL 6.76 Increased By ▲ 0.16 (2.42%)
FNEL 5.91 Increased By ▲ 0.06 (1.03%)
GGGL 11.30 Increased By ▲ 0.21 (1.89%)
GGL 16.78 Increased By ▲ 0.25 (1.51%)
GTECH 8.99 Increased By ▲ 0.58 (6.9%)
HUMNL 7.20 Increased By ▲ 0.06 (0.84%)
KEL 2.96 Decreased By ▼ -0.04 (-1.33%)
KOSM 3.46 Increased By ▲ 0.25 (7.79%)
MLCF 27.15 Increased By ▲ 0.15 (0.56%)
PACE 3.10 Increased By ▲ 0.10 (3.33%)
PIBTL 6.11 Increased By ▲ 0.17 (2.86%)
PRL 18.06 Increased By ▲ 0.16 (0.89%)
PTC 7.08 Increased By ▲ 0.11 (1.58%)
SILK 1.19 Increased By ▲ 0.02 (1.71%)
SNGP 34.75 Increased By ▲ 0.47 (1.37%)
TELE 10.94 Increased By ▲ 0.13 (1.2%)
TPL 9.40 Increased By ▲ 0.32 (3.52%)
TPLP 20.49 Increased By ▲ 0.34 (1.69%)
TREET 29.40 Increased By ▲ 0.25 (0.86%)
TRG 77.50 Increased By ▲ 0.39 (0.51%)
UNITY 20.36 Increased By ▲ 0.31 (1.55%)
WAVES 12.80 No Change ▼ 0.00 (0%)
WTL 1.37 Increased By ▲ 0.04 (3.01%)
YOUW 5.51 Increased By ▲ 0.52 (10.42%)
BR100 4,117 Increased By 16.2 (0.39%)
BR30 15,069 Increased By 42.6 (0.28%)
KSE100 41,630 Increased By 89.5 (0.22%)
KSE30 15,861 Increased By 56.2 (0.36%)
Pakistan

DRAP permits clinical trials of plasma therapy for Coronavirus treatment: Zafar Mirza

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ve
09 Apr, 2020
  • The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.
  • More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.
  • The companies will prepare quality sanitizers as per the directions of the World Health Organization.

ISLAMABAD: Special Assistant to the Prime Minister on National Health Services, Dr. Zafar Mirza Thursday announced that Drug Regulatory Authority of Pakistan (DRAP) has allowed the local production of raw material of cholorquine as part of efforts to cope with coronavirus challenge.

In a statement, he said the DRAP has also permitted clinical trials of plasma therapy for coronavirus treatment, Electronic/Radio channel reported.

The Special Assistant said the drug regulatory body has also allowed the clinical trials of locally manufactured ventilators.

More than fifty companies have been allowed to produce sanitizers to contain the spread of the pandemic.

The companies will prepare quality sanitizers as per the directions of the World Health Organization.

Comments

Comments are closed.